Article information
Full text is only aviable in PDF
Bibliografía
[1.]
American Medical Association.
Directory of practice parameters: titles, sources and updates.
American Medical Association, (1996),
[2.]
ECRI.
Health care standards 1997.
ECRI, (1997),
[3.]
J. Caminero Luna, L. Fernández Fau.
Recomendaciones SEPAR.
Doyma, (1998),
[4.]
M.S. Niederman.
Respiratory infections: an opportunity for integrated disease management.
Chest, 109 (1996), pp. 1.133-1.135
[5.]
M.J. Field, K.N. Lohr.
Clinical practice guidelines: direction of a new agency.
Institute of Medicine, (1990),
[6.]
L.A. Mandell, M. Niederman.
The Canadian community-acquired pneumonia consensus conference group.
Can J Infect Dis, 4 (1993), pp. 25-28
[7.]
M.S. Niederman, J. Bass, G.D. Campbell, A.M. Fein, R.F. Grossman, L.A. Mandell, et al.
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy.
Am Rev Respir Dis, 148 (1993), pp. 1.418-1.426
[9.]
SPILF Société de Pathologie Infectieuse de Langue Française.
Infections des voies respiratoires: conference de consensus en terapéutique anti-infectieuse. Rev Med Infect, 21 (1991), pp. 1-8
[10.]
G. Gialdroni-Grassi, L. Bianchi.
Guidelines for the management of community-adquired pneumonia in adults.
Monaldi Arch Dis Chest, 50 (1995), pp. 21-27
[11.]
British Thoracic Society.
Guidelines for the management of community-acquired pneumonia in adults admitted to hospital.
Br J Hosp Med, 49 (1993), pp. 349-350
[12.]
J. Dorca, S. Bello, J. Blanquer, R. De Celis, L. Molinos, A. Torres, et al.
Diagnóstico y tratamiento de la neumom’a adquirida en la comunidad.
Arch Bronconeumol, 33 (1997), pp. 240-246
[13.]
European study on community-acquired pneumonia (ESOCAP).
Guidelines for management of adult community-acquired lower respiratory tract infections.
Eur Respir I, 11 (1998), pp. 986-991
[14.]
Huchon G, Woodhead M, editores. Management of adult commuyniti-acquired lower respiratory tract infections. Eur Respir Rev 1998; 8: 391-426.
[15.]
R. Jackson, G. Feder.
Guidelines for clinical guidelines. A simple, pragmatic strategy for guideline development.
Br Med J, 317 (1998), pp. 427-428
[16.]
A. Hibble, D. Kanka, D. Pencheon, F. Pooles.
Guidelines in general practice: the new Tower o Babel?.
Br Med J, 317 (1998), pp. 862-863
[17.]
R. Grol, J. Dalhuijsen, S. Thomas, C. In’t Veld, G. Rutten, H. Mokkink.
Attributes of clinical guidelines that influence use of guidelines in general practice: observational study.
Br J Med, 317 (1998), pp. 858-861
[18.]
B. Jancin.
“Junk science” practice guidelines.
Intern Med News, (1995),
[19.]
S.H. Woolf.
Practice guidelines, a new reality in medicine. II Methods of developing guidelines.
Arch Intern Med, 152 (1992), pp. 946-952
[20.]
M.S. Niederman.
Community-acquired pneumonia. A North American perspective.
Chest, 113 (1998), pp. 179-182
[21.]
G. Gordon, D. Throop, L. Berberian, M.A. Westboro, M. Niederman, J. Bass, et al.
Validation of the therapeutic recommendations of the American Thoracic Society (ATS) guidelines for community-acquired pneumonia in hospitalized patients [resumen].
Chest, 110 (1996), pp. 55
[22.]
A. Torres, J. Dorca, R. Zalacaín, S. Bello, M. El-Ebiary, L. Molinos, et al.
Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicentre study.
Am J Respir Crit Care Med, 154 (1996), pp. 1.456-1.461
[23.]
P. Venkatesan, J. Gladman, J.T. McFarlane, D. Barer, P. Berman, W. Kinnear, et al.
A hospital study of community-acquired pneumonia in the elderly.
Thorax, 45 (1990), pp. 254-258
[24.]
R. Riquelme, A. Torres, M. El-Ebiary, J. Puig de la Bellacasa, R. Estruch, J. Mensa, et al.
Community-acquired pneumonia in the elderly. A multivariate analysis of risk and prognostic factors.
Am J Respir Crit Care Med, 154 (1996), pp. 1.450-1.455
[25.]
J. Rello.
Prescription of macrolides in community-acquired pneumonia.
Science or art?. Chest, 113 (1998), pp. 1.155-1.158
[26.]
M.A. Woodhead.
Atypical pneumonia.
Curr Opin Infect Dis, 10 (1997), pp. 101-102
[27.]
R.G. Finch, M.A. Woodhead.
Practical considerations and guidelines for the management of community-acquired pneumonia.
Drugs, 55 (1998), pp. 31-45
[28.]
F.W. Goldstein, J.F. Acar.
Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-1993 Western Europe and USA collaborative surveillance study.
J Antimicrob Chemother, 38 (1996), pp. 71-84
[29.]
A.J. Clavo, J.A. Girón, D. López, J. Canueto, A. Sánchez, A. Vergara, et al.
Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study.
Clin Infect Dis, 24 (1997), pp. 1.062-1.069
[30.]
J. Liñares, T. Alonso, J.L. Pérez, J. Ayats, M.A. Domínguez, R. Pallarés, et al.
Decreased susceptibility of penicillin-resistant pneumococcus to twenty-four beta-lactam antibiotics.
J Antimicrob Chemother, 30 (1992), pp. 279-288
[31.]
J.F. Plouffe, R.F. Breiman, R.R. Facklam.
Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention.
JAMA, 275 (1996), pp. 194-198
[32.]
G.V. Doern, A. Brueggemann, P. Holley, A.M. Rauch.
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
Antimicrob Agents Chemother, 40 (1996), pp. 1.208-1.213
[33.]
R. Pallarés, J. Liñares, M. Vadillo, C. Cabellos, F. Manresa, P.F. Viladrich, et al.
Resistance to penicillin and cephalosporine and mortality from severe pneumococcal pneumonia in Barcelona.
Spain. N Engl J Med, 333 (1995), pp. 474-480
[34.]
J. Rello, R. Rodríguez, P. Jubert, B. Álvarez.
Severe community-acquired pneumonia in the elderly: epidemiology and prognosis.
Clin Infect Dis, 23 (1996), pp. 723-728
[35.]
P.H. Edelstein.
Antimicrobial chemotherapy for legionnaires disease: time for a change.
Ann Intern Med, 129 (1998), pp. 328-330
[36.]
V.L. Yu.
New macrolides or new quinolones as monotherapy for patients with community-acquired pneumonia.
Our cup runneth over?. Chest, 113 (1998), pp. 1.158-1.159
[37.]
J. Tíias, M. Gomis, J. Prieto, J. Mensa, E. Bouza, J.A. García-Rodríguez, et al.
Tratamiento antibiótico empírico inicial de la neumom’a adquirida en la comunidad.
Rev Esp Quimioterapia 1998;, 11 (1998), pp. 255-261
[38.]
B.A. Cunha, K.W. Shea.
Emergence of antimicrobial resistance in community-acquired pulmonary pathogens.
Semin Respir Infect, 13 (1998), pp. 43-53
[39.]
M. Woodhead.
Community-acquired pneumonia guidelines.
An international comparison. A view from Europe. Chest, 113 (1998), pp. 183-187
[40.]
P. Gleason, W. Kapoor, R. Stone, J. Lave, D. Obrosky, R. Schulz, et al.
Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.
JAMA, 278 (1997), pp. 32-39
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
